Clinical and economic impact analysis of viscosupplementation with hylan G-F 20 versus hyaluronic acids and no viscosupplementation for the treatment of knee osteoarthritis in Colombia
Hylan G-F 20 showed reduced cost per surgery-free patient compared to hyaluronic acids and no viscosupplementation, enhancing knee replacement-free years.
Authors
- A. Upegui
- Pieralessandro Lasalvia (ORCID: https://orcid.org/0000-0002-8998-6608)
- Sergio Londoño (ORCID: https://orcid.org/0009-0006-1490-095X)
- Eliana C. Vásquez Melo
- Lina Maria Gómez Espitia
- Luz Karime Osorio Arango
Institutions
- Sanofi (France) (FR)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1080/14737167.2024.2442461
- Citations
- 1
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.47